A factor (ISFnp) suppressing proliferation and viability of thymoma EL
-4 cells in vitro was isolated from mouse liver, Screening based on me
asuring MTT-tetrazolium bioconversion to MTT-formazan by mitochondrial
enzymes of viable cells was used to obtain the factor as an individua
l chromatographic fraction. This enabled preparation of rabbit polyclo
nal antibodies. The protein peak was immunochemically homogeneous, sin
ce in the double immunodiffusion reaction the antiserum obtained forme
d a single precipitation line both with the purified factor preparatio
n and partly purified fractions containing ISFnp. The antiserum reacte
d with the ISFnp proper, since the antibody-carrying immunosorbent eli
minated biological activity from the factor-containing fractions. Doub
le immunodiffusion, gel filtration, and SDS-PAGE followed by immunoblo
tting have shown that the factor is orgoanospecifically localized in l
iver and consists of 40 and 42 kDa subunits that form. dimers of appar
ent mel. mass 70-80 kDa. In thymoma EL-4 cells the factor causes oligo
nucleosomal DNA fragmentation similar to DNA degradation in thymocyte
apoptosis caused by dexametasone. The fragmentation precedes EL-4 cell
lysis detected by Cr-51 release into the growth medium. This is a str
ict confirmation of the involvement of apoptosis in the mechanism of t
hymoma cell death. ISFnp practically completely inhibits blast-cell tr
ansformation in MLC response to a mutant MHC class 2 molecule. This ef
fect is not due to the death of normal T-cell antigen-reactive clones,
since in cultures treated with ISFnp during the first four days of cu
ltivation the factor removal is accompanied by the blast-cell transfor
mation, along with complete preservation of cell viability and the abi
lity for secondary proliferation response in MLC to the same antigen.